Gaudium IVF and Women Health LimitedGAUDIUMIVFCorporate

Medical Care Facilities Latest results: Jun 2026 6 quarters of data
₹101.46
MCap ₹738 Cr · P/E 31.9
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹19 Cr
Sales · Jun 2026
+9.1% YoY
₹2 Cr
Operating Profit · Jun 2026
-52.9% YoY
12.5%
OPM % · Jun 2026
-56.9% YoY
₹2 Cr
Net Profit · Jun 2026
-42.2% YoY
₹0.25
EPS · Jun 2026
-50.0% YoY

📝 Gaudium IVF and Women Health Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Gaudium IVF and Women Health Limited reported revenue of ₹19 crore for the quarter ended June 2026 (Q1 FY27), up 9.1% from ₹18 crore in the same quarter last year, and down 36.2% sequentially over the March 2026 quarter.

Net profit fell 42.2% year-on-year to ₹2 crore, from ₹3 crore. Earnings per share (EPS) came in at ₹0.25.

Operating profit stood at ₹2 crore — an operating margin (OPM) of 12.5%, compared with 29.0% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Gaudium IVF and Women Health Limited posted revenue of ₹104 crore, with a net profit of ₹24 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹106 crore with a net profit of ₹23 crore.

Valuation snapshot

At the current price of ₹101.46, GAUDIUMIVF has a market capitalisation of ₹738 crore and a trailing P/E of about 31.9.

Within the Medical Care Facilities industry, it is the 10th-largest of the 11 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 71.29%, foreign institutional investors (FIIs) 1.19%, domestic institutional investors (DIIs) 2.22%, public shareholders 25.29% of Gaudium IVF and Women Health Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹738 Cr
Current Price ?
₹101.5
P/E ?
31.91below ind
Industry P/E ?
56.40
P/B ?
N/A
P/S ?
6.97
P/FCF ?
N/A
Enterprise Value ?
N/A
EV/EBITDA ?
N/A
PEG ?
N/A
Earnings Yield ?
3.1%
Dividend Yield ?
N/A
Profitability & Returns
Sales (TTM) ?
₹106 Cr
OPM ?
32.9%
Profit after tax (TTM) ?
₹23 Cr
EPS (TTM) ?
₹3.18
ROCE ?
N/A
ROE ?
N/A
ROA ?
N/A
Growth
Sales — latest qtr ?
₹19 Cr
PAT — latest qtr ?
₹2 Cr
YoY qtr sales growth ?
9.1%
YoY qtr profit growth ?
-42.2%
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
N/A
Debt to Equity ?
N/A
Interest Coverage ?
10.1
Current Ratio ?
N/A
Ownership
Promoter holding ?
71.29%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
-29.4%
Return 6 months ?
4.7%

🗓️ Quarterly results (6 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 271832253019 +9.1% -36.2%
Operating Profit 95147122 -52.9% -80.1%
Other Income 000001 — +524.2%
Interest 001110 -24.8% -70.8%
Depreciation 011011 +18.3% +12.8%
Profit Before Tax 84135102 -39.4% -76.5%
Net Profit 639482 -42.2% -78.8%
EPS 1.050.501.530.591.150.25 -50.0% -78.3%
OPM % 32.4% 29.0% 43.4% 26.7% 40.1% 12.5% -56.9% -68.8%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric Prev FY FY26 TTM YoY %
Sales — ₹104 Cr ₹106 Cr —
Operating Profit — ₹38 Cr ₹35 Cr —
OPM % — 36.07% 32.95% —
NPM % — 23.42% 21.84% —
Other Income — ₹0 Cr ₹2 Cr —
Depreciation — ₹2 Cr ₹2 Cr —
Interest — ₹3 Cr ₹3 Cr —
EBIT — ₹35 Cr ₹32 Cr —
PBT — ₹32 Cr ₹31 Cr —
Tax — ₹1 Cr ₹2 Cr —
Net Profit — ₹24 Cr ₹23 Cr —
EPS — ₹3.77 ₹3.52 —
Material Cost — ₹12 Cr ₹20 Cr —
Employee Cost — ₹2 Cr ₹4 Cr —
Extraordinary Items — — — —

👥 Shareholding (latest 1 periods)

Metric Sep 2026 % Chg
Promoters 71.29% —
FIIs 1.19% —
DIIs 2.22% —
Public 25.29% —
No. of Shareholders 24,051 —

⚖️ Peer comparison

Industry: Medical Care Facilities · 11 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 APOLLOHOSP Apollo Hospitals ₹7,988.50 114,862 59.2 25,229 2,002 14.9% 7.9% 15.8% 33.1% 18.1% 32.9%
2 MAXHEALTH Max Healthcare ₹1,037.70 101,000 69.2 8,712 1,457 26.6% 16.7% 19.1% 34.1% 16.7% 4.9%
3 MANIPALHOS Manipal Health ₹710.85 93,504 — — — — — — — 28.2% -8.3%
4 FORTIS Fortis Healthcare ₹887.80 67,025 64.3 9,128 1,064 22.8% 11.7% 17.3% 31.4% 17.8% 44.1%
5 ASTERDM Aster DM ₹763.50 66,552 198.5 4,876 363 19.0% 7.5% 44.2% 138.8% 21.6% -68.9%
6 MEDANTA Global Health ₹1,445.60 38,846 69.8 4,683 553 20.9% 11.8% 19.4% 15.1% 26.5% -1.1%
7 NH Narayana Hrudayalaya ₹1,869.90 37,978 46.6 9,073 817 19.3% 9.0% 41.4% 1.9% 78.0% 5.4%
8 KIMS Krishna Institute ₹767.50 30,711 148.9 4,214 194 19.8% 4.6% 28.7% -41.5% 35.3% -56.0%
9 RAINBOW Rainbow Children's ₹1,450.00 14,710 51.6 1,820 290 31.6% 15.9% 12.4% 15.2% 33.2% 16.2%
10 GAUDIUMIVF Gaudium IVF ₹116.42 847 36.4 106 23 32.9% 21.8% — — 9.1% -42.2%
11 MOMSBELIEF Rays of Belief ₹223.00 466 — — — — — — — 136.4% 616.1%
❓ Frequently asked questions
What was Gaudium IVF and Women Health Limited's revenue in Q1 FY27?
Gaudium IVF and Women Health Limited reported revenue of ₹19 crore for the quarter ended June 2026 (Q1 FY27), up 9.1% from ₹18 crore in the same quarter last year, and down 36.2% sequentially over the March 2026 quarter.
What was Gaudium IVF and Women Health Limited's net profit in Q1 FY27?
Net profit fell 42.2% year-on-year to ₹2 crore, from ₹3 crore. Earnings per share (EPS) came in at ₹0.25.
What is GAUDIUMIVF's market capitalisation and P/E ratio?
At the current price of ₹101.46, GAUDIUMIVF has a market capitalisation of ₹738 crore and a trailing P/E of about 31.9.
Who owns Gaudium IVF and Women Health Limited? (shareholding pattern)
As of Sep 2026, promoters held 71.29%, foreign institutional investors (FIIs) 1.19%, domestic institutional investors (DIIs) 2.22%, public shareholders 25.29% of Gaudium IVF and Women Health Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI